A 12-week phase II placebo-controlled clinical trial with 255 patients with type 2 diabetes receiving KBP-042 has been completed (156), but further development of KBP-042 has been terminated by Eli Lilly and Nordic Bioscience to focus on the development of KBP-089, which is reportedly superior to KBP-042 (157, 158)
Next was the three-chamber test that was crucial for evaluating social behavior and was divided into two distinct phases.This was followed by phase 1, sociability that included a testing apparatus consisting of a 60 cm x 40 cm Plexiglas box with three interconnected chambers
AHK-Cu is a synthetic copper peptide engineered specifically for hair follicles
Vast amount of knowledge with regard to facial anatomy and how the ageing process affects our face
Li L, Li T, Qu X, Sun G, Fu Q, Han G